"Good to see both sides"
Oumou Maiga-Ascofaré is currently working as a research fellow at the Bernhard Nocht Institute for Tropical Medicine in Hamburg and at the Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR) in Kumasi, Ghana. We asked her about her work in DZIF and her life among different cultures.
A list of pathogens sets priorities for antibiotic research
The WHO has published a list of 12 bacteria groups which are to be given priority for future new antibiotic research and development. DZIF scientists at the University of Tübingen were substantially involved in developing this priority list.
Rapid test detects mobile resistance gene mcr-1
Scientists from the German Center for Infection Research (DZIF) and the Justus Liebig University Giessen (JLU) have evaluated a rapid test that detects the dreaded colistin resistance gene within twenty minutes.
New malaria vaccine effective in clinical trial
Researchers of the University of Tübingen and DZIF in collaboration with the biotech company Sanaria Inc. have demonstrated in a clinical trial that a new vaccine for malaria called Sanaria® PfSPZ-CVac has been up to 100 percent effective when assessed at 10 weeks after last dose of vaccine.
29 March 2017 - PRESS RELEASE
Researchers from the University of Tübingen and the DZIF show medicine is effective when the timing is right. Their new active substance – DSM 265 – demonstrated a good prophylactic effect for Malaria. 21 healthy volunteers participated in the trial. The results have been published in the medical journal The Lancet Infectious Diseases. [ more ]
09 March 2017 - PRESS RELEASE
27 February 2017 - INTERVIEW
DZIF e. V. – Inhoffenstraße 7, 38124 Braunschweig, Germany
PHONE +49 531-6181 1152 EMAIL firstname.lastname@example.org